Can you provide the last earnings date for PERSPECTIVE THERAPEUTICS INC?
PERSPECTIVE THERAPEUTICS INC (CATX) last reported earnings on 3/16/2026.
NYSEARCA:CATX • US46489V3024
Past quarterly earnings results for PERSPECTIVE THERAPEUTICS INC (CATX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.51 | -0.36 | -40.27% | -104.00% | 43K | 219.932K | -80.45% | -81.62% |
| Q3 2025 | -0.35 | -0.33 | -5.16% | -66.67% | 209K | 228.307K | -8.46% | -43.36% |
| Q2 2025 | -0.29 | -0.31 | 5.80% | -61.11% | 290K | 157.549K | 84.07% | -44.87% |
| Q1 2025 | -0.25 | -0.31 | 20.23% | -25.00% | 342K | 147.186K | 132.36% | 5.23% |
| Q4 2024 | -0.25 | -0.27 | 7.98% | 71.59% | 234K | 249.064K | -6.05% | -88.50% |
| Q3 2024 | -0.21 | -0.22 | 3.49% | 47.50% | 369K | 269.392K | 36.98% | -83.11% |
| Q2 2024 | -0.18 | -0.21 | 15.97% | -800.00% | 526K | 161.843K | 225.01% | -74.83% |
| Q1 2024 | -0.20 | -0.24 | 15.95% | - | 325K | - | -84.22% | |
| Q4 2023 | -0.88 | -0.37 | -135.27% | -8,700.00% | 2.034M | 1.953M | 4.15% | 10.54% |
| Q3 2023 | -0.40 | -0.41 | 1.96% | -3,900.00% | 2.185M | 2.244M | -2.63% | 27.03% |
| Q2 2023 | -0.02 | -0.01 | -96.08% | -100.00% | 2.09M | - | -16.73% | |
| Q1 2023 | - | - | 2.06M | - | -29.21% | |||
| Q4 2022 | -0.01 | -0.01 | 1.96% | - | 1.84M | 2.901M | -36.57% | -34.75% |
| Q3 2022 | -0.01 | -0.01 | -30.72% | - | 1.72M | 3.175M | -45.83% | -32.81% |
| Q2 2022 | -0.01 | -0.01 | -30.72% | - | 2.51M | 3.008M | -16.56% | -7.38% |
| Q1 2022 | -0.02 | -0.01 | -96.08% | -100.00% | 2.91M | 2.535M | 14.79% | 11.92% |
| Q4 2021 | -0.01 | -0.01 | 1.96% | 50.00% | 2.82M | 2.754M | 2.40% | 19.49% |
| Q3 2021 | -0.01 | -0.01 | 1.96% | - | 2.56M | 2.475M | 3.43% | 7.56% |
| Q2 2021 | -0.01 | -0.01 | 1.96% | - | 2.71M | 2.433M | 11.39% | 18.86% |
| Q1 2021 | -0.01 | -0.01 | 1.96% | - | 2.6M | 2.911M | -10.68% | -9.72% |
| Q4 2020 | -0.02 | -0.02 | -30.72% | - | 2.36M | 2.754M | -14.31% | - |
| Q3 2020 | -0.01 | -0.01 | 26.45% | - | 2.38M | 2.605M | -8.64% | - |
| Q2 2020 | -0.01 | -0.01 | 26.45% | - | 2.28M | 2.352M | -3.06% | - |
| Q1 2020 | -0.01 | -0.02 | 50.98% | - | 2.88M | 1.989M | 44.80% | - |
Notes
PERSPECTIVE THERAPEUTICS INC (CATX) last reported earnings on 3/16/2026.
PERSPECTIVE THERAPEUTICS INC (CATX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, PERSPECTIVE THERAPEUTICS INC (CATX) has beaten EPS estimates in 3 out of 4 releases.